It has been reported that SIRT1 reduction in AD increases acetylation of MeCP2, thereby preventing its binding to HDAC1 and SWI/SNF DNA helicase/ATPase (ATRX) and enabling its binding to DNMT1 458, 463-465. The gene discussed is MECP2; the disease is Alzheimer disease.